key: cord-0965492-e5bu0ok5 authors: Sallam, M. title: COVID-19 vaccine hesitancy worldwide: a systematic review of vaccine acceptance rates date: 2021-01-04 journal: nan DOI: 10.1101/2020.12.28.20248950 sha: d1a2bd66a523ff4f0e6f8b4215e22b1b99f371c6 doc_id: 965492 cord_uid: e5bu0ok5 Introduction: Utility of vaccine campaigns to control coronavirus disease 2019 (COVID-19) is not merely dependent on vaccine efficacy and safety. Vaccine acceptance among the general public and the healthcare workers, appears to have a decisive role for successful control of the pandemic. Aim: To provide an up-to-date assessment of COVID-19 vaccination acceptance rates worldwide. Methods: A systematic search of the peer-reviewed English survey literature indexed in PubMed was done on December 25, 2020. Results from 30 studies, met the inclusion criteria and formed the basis for final COVID-19 vaccine acceptance estimates. Results of an additional recent survey from Jordan and Kuwait was considered in this review as well. Results: Survey studies on COVID-19 vaccine acceptance rates were found from 33 different countries. Among adults representing the general public, the highest COVID-19 vaccine acceptance rates were found in Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%) and China (91.3%). On the other hand, the lowest COVID-19 vaccine acceptance rates were found in Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia (54.9%), Poland (56.3%), US (56.9%), and France (58.9%). Only eight surveys among healthcare workers (doctors, nurses) were found, with vaccine acceptance rates ranging from 27.7% in the Democratic Republic of the Congo to 78.1% in Israel. In a majority of survey studies among the general public (62%), the acceptance of COVID-19 vaccination showed a level of [≥] 70%. Conclusions: Low rates of COVID-19 vaccine acceptance were reported in the Middle East, Russia, Africa and several European countries. This could represent a major problem in the global efforts that aim to control the current COVID-19 pandemic. More studies are recommended to address the scope of COVID-19 vaccine hesitancy. Such studies are particularly needed in the Middle East Africa, Eastern Europe, Central Asia, Middle and Latin America. Based on Strategic Advisory Group of Experts on Immunization (SAGE), vaccine hesitancy is the term used to describe: "delay in acceptance or refusal of vaccination despite availability of vaccination services" [1] . Factors that affect the attitude towards acceptance of vaccination include complacency, convenience and confidence [1, 2] . Complacency denotes the low perception of the disease risk; hence, vaccination deemed unnecessary. Confidence refers to the trust in vaccination safety, effectiveness, besides the competence of the healthcare systems. Convenience entails the availability, affordability and delivery of vaccines in a comfortable context [2] . The complex nature of motives behind vaccine hesitancy can be analyzed using the epidemiologic triad of environmental, agent and host factors [3, 4] . Environmental factors include public health policies, social factors and the messages spread by media is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint commonly occur in severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) genome [13] [14] [15] [16] [17] [18] . The viral factors can be particularly of high relevance considering the recent reports of resurgence in COVID-19 infections in UK due to a new variant of the virus [19] . The global efforts to lessen the effects of the pandemic, and to reduce the health and socio-economic impact relies to a large extent on the preventive efforts [20, 21] . Thus, huge efforts by the scientific community and pharmaceutical industry backed by governments' support, were directed towards developing efficacious and safe vaccines for SARS-CoV-2 [22] . These efforts were manifested by approval of three vaccines, in addition to more than 60 vaccine candidates in clinical trials. Moreover, more than 170 COVID-19 vaccine candidates are in the pre-clinical phase [23] . Despite the huge efforts made to achieve successful COVID-19 vaccines, a major hindrance can be related to vaccine hesitancy towards the approved and prospective COVID-19 vaccination [24] . To identify the scope of this problem, this systematic review aimed to assess the acceptance rates for COVID-19 vaccine(s) in different countries worldwide. . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint This review was conducted following the PRISMA guidelines [25] . Published papers in PubMed/Medline that aimed at evaluating COVID-19 vaccine hesitancy/vaccine acceptance using a survey/questionnaire were eligible for inclusion in this review. Only studies in English language that met the inclusion criteria were considered in this review. Screening of titles and abstracts was conducted, followed by data extraction for the following items: Date of survey, country/countries in which the survey was conducted, target population for survey (e.g. general public, healthcare workers, students), total number of respondents, and COVID-19 vaccine acceptance rate (which included the number of respondents who answered: agree/somewhat/completely agree/leaning towards yes/definitely yes). . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint A total of 178 records were identified, and following the screening process, a total of 30 articles were included in this review (Figure 1 ). In addition, data collected in an is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint The results of COVID-19 vaccine acceptance rates in different studies included in this review and stratified by country are shown in (Table 1) . Classified per study, the highest vaccine acceptance rates (>90%) among the general public were found in four studies from Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%) and China (91.3%). On the contrary, the lowest vaccine acceptance rates (<60%) among the general public were found in seven studies from Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia For the three studies conducted among parents/guardians, the vaccine acceptance rates were more than 70%. For the two studies among University students, the vaccine acceptance rate was 44.2% in Malta and 86.1% in Italy. In countries with multiple surveys over time, the following changes in COVID-19 vaccine acceptance rates were observed: In UK, the vaccine acceptance rate was 79.0% in April, 86.0% in May, 71.5% in June, 64.0% in July and 71.7% in September/October. In France, the vaccine acceptance rate ranged from 62.0% to 77.1% in March/April and is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint 13 was 58.9% in June. In Italy, the vaccine acceptance rate was 77.3% in April, 70.8% in June and reached 53.7% in September. For the vaccine acceptance rates in US, it was 56.9% in April, and ranged from 67.0% to 75.0% in May, and reached 75.4% in June. In China, three studies reported high rates of vaccine acceptance with the first study that reported a vaccine acceptance rate of 91.3% in March, the second study reported a rate of 83.5% in May and the third study reported a rate of 88.6% in June. . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint Vaccine hesitancy is an old phenomenon that represents a serious threat to the global health, as shown in resurgence of some infectious diseases (e.g. outbreaks of measles and pertussis) [57] [58] [59] [60] [61] . The huge leaps in developing efficacious and safe COVID-19 vaccines within a short period were unprecedented [62] [63] [64] . Nevertheless, COVID-19 vaccine hesitancy can be the limiting step in the global efforts to control the current pandemic with its negative health and socio-economic effects [24, 65, 66] . Assessing the level of population immunity necessary to limit the pathogen spread is dependent on the basic reproductive number for that infectious disease [67] . The latest estimates on COVID-19, pointed to the range of 60-75% immune individuals that would be necessary to halt the forward transmission of the virus and community spread of the virus [68] [69] [70] . Vaccine cost, effectiveness and duration of protection appear as important factors to achieve such a goal [64, 71, 72] . However, vaccine hesitancy can be a decisive factor for successful control of the current COVID-19 pandemic [24, 73] . Thus, estimates of vaccine acceptance rates can be helpful to plan actions and intervention measures necessary to increase the awareness and assure people about the safety and benefits of vaccines, which in turn would help to control virus spread and alleviate the negative effects of this unprecedented pandemic [74, 75] . In this review, a large variability in COVID-19 vaccine acceptance rates was found. However, certain patterns can be deduced based on descriptive analysis of the reported vaccine acceptance rates. First, in East and South East Asia, the overall . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint Also, the vaccine acceptance rates were relatively high in Latin America, where results from Brazil and Ecuador reported more than 70% acceptance rates [27, 39] . This was also seen in the survey from Mexico with a vaccine acceptance rate of 76.3% [27] . In Europe, the results were largely variable, with countries around the Mediterranean reporting vaccine acceptance rates as low as 53.7% in Italy, 58.9% in France; while no surveys among general public in Malta were found [27, 53] . However, the vaccine acceptance rates among students and healthcare workers in Malta were 44.2% and 52.0%, respectively [54, 55] . Variable results were also reported in other European countries with rates as high as 80.0% in Denmark, and as low as 56.3% in Poland is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint https://www.ecdc.europa.eu/en/publications-data/threat-assessment-briefrapid-increase-sars-cov-2-variant-united-kingdom (accessed on 26-12-2020). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 4, 2021. ; https://doi.org/10.1101/2020.12.28.20248950 doi: medRxiv preprint Sage Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants of the COVID-19 epidemic in Wuhan, China: a modelling study School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review Rational use of face masks in the COVID-19 pandemic Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey Parental acceptability of COVID-19 vaccination for children under the age of 18 years in China: cross-sectional online survey Attitudes towards influenza vaccine and a potential COVID-19 vaccine in Italy and differences across occupational groups Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination Vaccine hesitancy in the University of Malta Faculties of Health Sciences, Dentistry and Medicine vis-a-vis influenza and novel COVID-19 vaccination Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis Anti-Vaccine Decision-Making and Measles Resurgence in the United States. Glob Pediatr Health Impact of anti-vaccine movements on pertussis control: the untold story The re-emergency and persistence of vaccine preventable diseases Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country Developing Covid-19 vaccines at 63 Rapid COVID-19 vaccine development A Review of the Progress and Challenges of Developing a Vaccine for COVID-19 Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines (Basel) 2020 Immediate impact of stay-at-home orders to control COVID-19 transmission on socioeconomic conditions, food insecurity, mental health, and intimate partner violence in Bangladeshi women and their families: an interrupted time series Unraveling r 0: Considerations for public health applications Reproductive number of coronavirus Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2 The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation COVID vaccination logistics: five steps to take now Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now: Analysis describe lessons learned from past pandemics and vaccine campaigns about the path to successful vaccine delivery for COVID-19 Ten considerations for effectively managing the COVID-19 transition Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. The Lancet Public Health Physical and mental health impacts of COVID-19 on healthcare workers: a scoping review The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study